Efficacy and rapid response of certolizumab pegol liquid formulation in combination with methotrexate (MTX) in patients with active rheumatoid arthritis despite MTX therapy: results from the RAPID 2 study.

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
RevistaProgram and abstracts of the American College of Rheumatology (ACR) 71st Annual Meeting
Año 2007
Este artículo no tiene resumen
Epistemonikos ID: da0a021c469de4c8b134d8d04df7a729792ebf3b
First added on: Nov 02, 2017